Citadel Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.18M Buy
531,000
+124,100
+30% +$934K ﹤0.01% 5149
2025
Q4
$2.92M Sell
406,900
-24,500
-6% -$194K ﹤0.01% 5217
2025
Q3
$4.61M Buy
431,400
+17,900
+4% +$176K ﹤0.01% 4510
2025
Q2
$4M Buy
413,500
+103,500
+33% +$1.07M ﹤0.01% 4490
2025
Q1
$4.62M Sell
310,000
-101,500
-25% -$1.56M ﹤0.01% 4003
2024
Q4
$6.14M Buy
411,500
+183,600
+81% +$2.99M ﹤0.01% 3637
2024
Q3
$4.36M Buy
227,900
+42,000
+23% +$871K ﹤0.01% 4171
2024
Q2
$3.85M Sell
185,900
-56,100
-23% -$1.11M ﹤0.01% 4166
2024
Q1
$4.55M Sell
242,000
-36,500
-13% -$626K ﹤0.01% 4087
2023
Q4
$4.02M Buy
278,500
+195,900
+237% +$2.66M ﹤0.01% 4115
2023
Q3
$1.43M Sell
82,600
-84,800
-51% -$1.77M ﹤0.01% 5859
2023
Q2
$3.48M Sell
167,400
-500
-0.3% -$10.9K ﹤0.01% 4205
2023
Q1
$3.95M Buy
167,900
+42,750
+34% +$1.15M ﹤0.01% 4182
2022
Q4
$3.5M Sell
125,150
-18,220
-13% -$466K ﹤0.01% 4503
2022
Q3
$3.35M Buy
143,370
+6,250
+5% +$189K ﹤0.01% 4582
2022
Q2
$4.63M Sell
137,120
-66,460
-33% -$2.33M ﹤0.01% 3946
2022
Q1
$7.11M Sell
203,580
-147,280
-42% -$5.04M ﹤0.01% 3520
2021
Q4
$10.7M Buy
350,860
+42,760
+14% +$1.39M ﹤0.01% 2968
2021
Q3
$10.1M Buy
308,100
+162,600
+112% +$5.2M ﹤0.01% 3063
2021
Q2
$4.4M Buy
+145,500
New +$4.79M ﹤0.01% 4711

Other funds holding OGN

Citadel Advisors's OGN Position: Q1 2026 in Review

Citadel Advisors reduced its Organon & Co (OGN) stake by 3.1% in Q1 2026, selling an estimated $486K and leaving 1,998,390 shares worth $12M. The position accounts for ﹤0.01% of the portfolio, ranked #3008.

Citadel Advisors first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $116M in Q1 2024. 604 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Citadel Advisors held 1,998,390 shares of Organon & Co worth $12M as of Q1 2026.
  • Citadel Advisors sold 64,584 Organon & Co shares in Q1 2026, an estimated $486K.
  • Organon & Co made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3008 holding.
  • Citadel Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
  • Citadel Advisors's Organon & Co position peaked at $116M in Q1 2024.
  • 604 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.